We are live on ! Find out more
SBSB

Sullivan, Bruyette, Speros & Blaney Portfolio holdings

AUM $2.27B
1-Year Est. Return 50.71%
This Fund
S&P 500
This Quarter Est. Return
+11%
1 Year Est. Return
+50.71%
3 Year Est. Return
+46.71%
5 Year Est. Return
+87.02%
10 Year Est. Return
AUM
$1.64B
AUM Growth
+$177M
Cap. Flow
+$19.1M
Cap. Flow %
1.17%
Top 10 Hldgs %
77.89%
Holding
221
New
28
Increased
82
Reduced
62
Closed
8

Sector Composition

Rank Sector Weight
1 Technology 2.93%
2 Healthcare 1.94%
3 Financials 1.16%
4 Energy 0.8%
5 Consumer Staples 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VIG icon
26
Vanguard Dividend Appreciation ETF
VIG
$111B
$4.7M 0.29%
42,868
AMZN icon
27
Amazon
AMZN
$2.87T
$4.45M 0.27%
49,980
+2,880
+6% +$240K
PFE icon
28
Pfizer
PFE
$143B
$4.1M 0.25%
101,694
+4,438
+5% +$178K
CVX icon
29
Chevron
CVX
$388B
$3.87M 0.24%
31,399
-225
-0.7% -$26.6K
VUG icon
30
Vanguard Morningstar Growth ETF
VUG
$218B
$3.36M 0.21%
129,018
MUB icon
31
iShares National Muni Bond ETF
MUB
$45.1B
$3.27M 0.2%
29,410
D icon
32
Dominion Energy
D
$61.4B
$3.19M 0.19%
41,650
+29,112
+232% +$2.13M
GLD icon
33
SPDR Gold Trust
GLD
$131B
$2.8M 0.17%
22,949
+2,080
+10% +$256K
VNQI icon
34
Vanguard Global ex-US Real Estate ETF
VNQI
$3.51B
$2.74M 0.17%
45,931
PG icon
35
Procter & Gamble
PG
$335B
$2.63M 0.16%
25,289
-472
-2% -$45.9K
IAU icon
36
iShares Gold Trust
IAU
$62.8B
$2.63M 0.16%
106,078
-40,629
-28% -$1.01M
JPM icon
37
JPMorgan Chase
JPM
$940B
$2.6M 0.16%
25,691
+2,594
+11% +$267K
SCHE icon
38
Schwab Emerging Markets Equity ETF
SCHE
$12.5B
$2.45M 0.15%
94,314
+1
+0% +$25
MINT icon
39
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$16.9B
$2.45M 0.15%
24,128
+7,701
+47% +$780K
SCHG icon
40
Schwab US Large-Cap Growth ETF
SCHG
$59.1B
$2.32M 0.14%
233,408
+1,056
+0.5% +$9.99K
BRK.B icon
41
Berkshire Hathaway Class B
BRK.B
$1.1T
$2.19M 0.13%
10,892
+238
+2% +$48K
IBM icon
42
IBM
IBM
$207B
$2.15M 0.13%
15,913
+2,629
+20% +$335K
MRK icon
43
Merck
MRK
$323B
$2.13M 0.13%
26,862
+8,630
+47% +$645K
IWD icon
44
iShares Russell 1000 Value ETF
IWD
$81.9B
$2.06M 0.13%
16,684
-8
-0% -$961
IRWD icon
45
Ironwood Pharmaceuticals
IRWD
$677M
$1.99M 0.12%
175,880
+129,135
+276% +$1.44M
MCD icon
46
McDonald's
MCD
$192B
$1.86M 0.11%
9,794
-221
-2% -$40.1K
DHR icon
47
Danaher
DHR
$137B
$1.83M 0.11%
15,658
+589
+4% +$60.4K
DIA icon
48
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$45.6B
$1.74M 0.11%
6,710
-38
-0.6% -$9.56K
IWF icon
49
iShares Russell 1000 Growth ETF
IWF
$120B
$1.73M 0.11%
45,836
IWV icon
50
iShares Russell 3000 ETF
IWV
$19.5B
$1.67M 0.1%
10,022
+15
+0.1% +$2.41K

Similar funds

Sullivan, Bruyette, Speros & Blaney's Q1 2019 Portfolio in Review

As of Q1 2019, Sullivan, Bruyette, Speros & Blaney held 221 positions worth $1.64B, up 12% from $1.46B the previous quarter. Its ten largest holdings account for 78% of the portfolio.

Sullivan, Bruyette, Speros & Blaney's Q1 2019 filing shows 28 new, 82 increased, 62 reduced and 8 closed positions. Its largest new stake was Chubb: 9,320 shares worth $1.31M. The largest sale was iShares Core MSCI Emerging Markets ETF, an estimated $9.17M.

By sector, the portfolio is most concentrated in Technology at 2.9% of assets, up from 2.7% a quarter earlier, followed by Healthcare and Financials.

  • Sullivan, Bruyette, Speros & Blaney's largest Q1 2019 buy was Chubb: 9,320 shares worth $1.31M.
  • Sullivan, Bruyette, Speros & Blaney added most to Vanguard FTSE Developed Markets ETF in Q1 2019, an estimated $7.51M increase.
  • Sullivan, Bruyette, Speros & Blaney's biggest Q1 2019 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $9.17M.
  • Sullivan, Bruyette, Speros & Blaney fully exited Scana in Q1 2019, selling an estimated $2.4M.
  • Sullivan, Bruyette, Speros & Blaney's ten largest holdings make up 78% of its $1.64B portfolio in Q1 2019.
  • Sullivan, Bruyette, Speros & Blaney opened 28 new positions and closed 8 in Q1 2019.
  • Sullivan, Bruyette, Speros & Blaney's portfolio value rose 12% quarter-over-quarter to $1.64B.

Based on Sullivan, Bruyette, Speros & Blaney's 13F filing for Q1 2019, filed 8 May 2019.